Navigation Links
Takeda Launches New Subsidiary in Ecuador
Date:3/21/2013

; (Pinaverium bromide, Dimeticone) and Tecta® (pantoprazole magnesium) and its gynaecology product, Albothyl (Policresulen), which Takeda repatriated following the Nycomed acquisition.

Takeda Ecuador plans to leverage its sales platform with a steady stream of product launches from its existing portfolio and R&D pipeline.

Carlos Haro has been appointed country manager for Ecuador. He joins the Company from Sanofi, where he was the General Manager for Ecuador. He will lead the start-up team which will grow steadily as the Company expands its portfolio and enters new therapeutic areas.

"The launch of our subsidiary in Ecuador reinforces Takeda's position in Latin America and will enable us to meet the diverse healthcare needs of the population. We have an established product portfolio, which will give us a strong starting point and we look forward to launching our novel medicines into the market," said Norbert Oppitz , Senior Vice President, Latin America, at Takeda "This investment further demonstrates our commitment to Latin America and its growth potential. We have ambitious plans in this region and we continue to evaluate opportunities to expand our footprint."

*Data Source:© 2012 IMS Health. All rights reserved. Estimate based on Market Prognosis Global 2012-2016.  


About Takeda Pharmaceuticals International GmbH

Takeda Pharmaceuticals International GmbH, headquartered in Zurich, is a wholly owned subsidiary of Takeda Pharmaceutical Company Limited. As the largest pharmaceutical company in Japan and a leader in the global industry, Takeda's mission is to strive toward better health for patients
'/>"/>

SOURCE Takeda Pharmaceuticals International GmbH
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Takeda lanza nueva subsidiaria en Ecuador
2. Scripps Research Institute and Takeda Pharmaceuticals Announce Expanded Research Collaboration
3. Takeda presenta la richiesta di autorizzazione allimmissione in commercio nellUnione Europea per Vedolizumab nella colite ulcerosa moderata-grave e nella malattia di Crohn
4. Takeda Submits Marketing Authorisation Application for Vedolizumab in Moderately to Severely Active Ulcerative Colitis and Crohns Disease in the European Union
5. Takeda and Resolve Therapeutics Enter Autoimmune Partnership
6. Takeda Receives FDA Approval for Three New Type 2 Diabetes Therapies, NESINA (alogliptin) and Fixed-Dose Combinations OSENI (alogliptin and pioglitazone) and KAZANO (alogliptin and metformin HCl)
7. FDA Accepts Takeda and Lundbecks Submission of the New Drug Application for Vortioxetine for the Treatment of Major Depressive Disorder
8. Takedas Deerfield Campus Ranked Among Chicagos Top 100 Workplaces in 2012
9. Takeda Completes its Russian Pharmaceutical Manufacturing Facility
10. Takeda Resubmits New Drug Applications to the United States Food and Drug Administration for Alogliptin and the Fixed-Dose Combination Alogliptin and Pioglitazone
11. Zacks Bull and Bear of the Day Highlights: Discover Financial Services, POSCO, AstraZeneca, Bayer and Takeda Pharmaceutical
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/4/2015)... , Aug. 4, 2015 Organovo ... biology company focused on delivering scientific and medical ... the Company has hired Paul Gallant ... tissue service and product business. Mr. Gallant has more ... in the drug discovery industry, most recently serving ...
(Date:8/4/2015)... -- Research and Markets ( ... PharmaBiotech,s new report "Animal Biotechnology - Technologies, ... This report describes and evaluates animal biotechnology ... as well as improvement in food production. Knowledge ... of biotechnology to manage genetic disorders and improve ...
(Date:8/4/2015)... EDISON, N.J. , Aug. 4, 2015 /PRNewswire/ ... biopharmaceutical company focused on the development and commercialization ... Sapirstein , Chief Executive Officer, will present live ... DATE: Thursday, August 6, 2015 TIME: 12:15PM EDT ... will be a live, interactive online event where ...
Breaking Medicine Technology:Organovo Holdings, Inc. Appoints Paul Gallant as General Manager 2Organovo Holdings, Inc. Appoints Paul Gallant as General Manager 3Animal Biotechnology 2014-2024 - 2015 Technologies, Markets and Companies Analysis 2Animal Biotechnology 2014-2024 - 2015 Technologies, Markets and Companies Analysis 3ContraVir to Webcast Investor Presentation on August 6: VirtualInvestorConferences.com 2ContraVir to Webcast Investor Presentation on August 6: VirtualInvestorConferences.com 3
... N.J., Oct. 12, 2011 Savient Pharmaceuticals, Inc. (NASDAQ: ... financial results for the third quarter 2011 prior to the ... John H. Johnson, Chief Executive Officer and President, ... Officer, will host an investment community conference call beginning at ...
... 12, 2011 If you could learn that you have a ... and 75 percent of that chance could be altered by lifestyle ... of the nation,s leading online direct-to-consumer online lab test and health ... Your Number HealthScore as seen on The Biggest Loser ...
Cached Medicine Technology:Savient Pharmaceuticals to Hold Third Quarter 2011 Financial Results Conference Call on Thursday, November 3, 2011 2PersonaLabs and BioSignia Join to Offer Targeted Risk Assessment 2
(Date:8/4/2015)... ... August 04, 2015 , ... They say a picture is worth a ... pictures and medical art can be essential. StayWell, a health solutions company, announced today ... Education solutions have been used by physicians and other health care providers for more ...
(Date:8/4/2015)... San Francisco, Calif. (PRWEB) , ... August 04, ... ... services to corporations, law firms and government entities, today announced that John Munro, ... leadership team as Vice President of Managed Services Operations. , “I am thrilled ...
(Date:8/4/2015)... ... August 04, 2015 , ... Patients are ... offered by the world renowned Beverly Hills facelift surgeon , Dr. Paul ... surgery techniques helps individuals to achieve an outer appearance that meets their personal ...
(Date:8/4/2015)... , ... August 04, 2015 , ... T.E.N., an information ... vendor participating in The ISE® Lions’ Den and Jungle Lounge 2015, which will be ... Las Vegas. , During the event, eight emerging security vendors, known as “Gazelles,” will ...
(Date:8/4/2015)... ... August 04, 2015 , ... ... look at unique artistic expressions from a diverse group of exceptionally talented female ... Beautiful Music & Art Festival on September 25-27, 2015 in Downtown Las Vegas. ...
Breaking Medicine News(10 mins):Health News:StayWell Offers Instant Downloads, Licensing of Medical Art to Improve Patient Education 2Health News:StayWell Offers Instant Downloads, Licensing of Medical Art to Improve Patient Education 3Health News:John Munro Joins eDiscovery Leader Discovia as Vice President of Managed Services Operations 2Health News:John Munro Joins eDiscovery Leader Discovia as Vice President of Managed Services Operations 3Health News:Beverly Hills Surgeon, Dr. Paul Nassif, is Now Offering Personal Consultations with Full Examinations for Facial Plastic Surgeries 2Health News:Beverly Hills Surgeon, Dr. Paul Nassif, is Now Offering Personal Consultations with Full Examinations for Facial Plastic Surgeries 3Health News:T.E.N. Releases Pitch Schedule for The ISE® Lions Den & Jungle Lounge 2015 2Health News:T.E.N. Releases Pitch Schedule for The ISE® Lions Den & Jungle Lounge 2015 3Health News:T.E.N. Releases Pitch Schedule for The ISE® Lions Den & Jungle Lounge 2015 4Health News:Sin City Gallery Rocks Life Is Beautiful Festival with INTIMATELY FEMALE at Art Motel 2Health News:Sin City Gallery Rocks Life Is Beautiful Festival with INTIMATELY FEMALE at Art Motel 3Health News:Sin City Gallery Rocks Life Is Beautiful Festival with INTIMATELY FEMALE at Art Motel 4
... HIV vaccine in a constrained global economy, cost-effective prevention ... must take a larger role in efforts to decrease ... HIV/AIDS vaccine researcher Susan Allen, MD, MPH. Allen, ... Africa for more than 25 years, highlighted the value ...
... Seth Field, MD, PhD, associate professor in the Department ... a five-year, $3.86 million "Era of Hope Scholar Award" ... The award supports individuals who have high potential ... careers, researchers considered the "best and brightest" in their ...
... 2010 DNA methylation a modification of DNA linked ... a blood cancer called multiple myeloma, according to a study ... And at specific points of DNA, "global hypomethylation," in ... the step-by-step development of myeloma, according to a scientific paper ...
... The potential for stem cells derived from menstrual ... by researchers at the University of South Florida, Cryo-Cell ... Oldsmar, FL, and Saneron CCEL Therapeutics, Inc. a Tampa-based ... $100,000 grant from the Florida-based Technology Transfer/ Commercialization Partnership ...
... today that Martin J. Blaser, MD, the Frederick H. ... Center has been awarded one of only twenty NIH ... "Disappearing Gastrointestinal Microbiota in Epidemic Obesity. The project ... a result of antibiotic use early in life has ...
... Virginia Tech,s College of Natural Resources and Environment, has ... Mycobacterium tuberculosis complex, a group of pathogens that ... been nearly two decades since a new organism was ... the early and mid 20th century. Tuberculosis is ...
Cached Medicine News:Health News:Testing African couples for HIV is cost-effective prevention strategy 2Health News:TGen-Mayo Clinic study discovers role of DNA methylation in multiple myeloma blood cancer 2Health News:Study to investigate menstrual blood-derived stem cells as potential stroke therapy 2Health News:NYU Langone Medical Center receives NIH Director's Transformative Research Projects award 2Health News:NYU Langone Medical Center receives NIH Director's Transformative Research Projects award 3Health News:Virginia Tech professor discovers new TB pathogen 2Health News:Virginia Tech professor discovers new TB pathogen 3
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: